Researchers found that 18% of patients with advanced ovarian cancer remained disease-free for at least 10 years after receiving chemotherapy and were likely cured.
A randomized study sought to determine the effect of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy on HRQOL for patients with advanced ovarian cancer.